Belpointe PREP LLC Class A OZ 深 沪
已收盘 10-10 16:00:00 美东时间
64.05
-0.425
-0.66%
华盛通- 最 高64.435
- 今 开64.40
- 成交量 1486股
- 最 低 64.05
- 昨 收 64.475
- 总市值 2.43亿
- 52周最高 82.89
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 56.77
- 委 比 0.00%
- 总股本 378.67万
- 历史最高 114.885
- 量 比 0.57
- 振 幅 0.60%
- 历史最低 42.75
- 每 手 1
- 风险率 4.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Belpointe OZ Secures $204 Million Loan to Refinance Aster & Links in Sarasota, FL
Belpointe OZ has completed a $204.14 million refinancing transaction for its Sarasota development, Aster & Links, reducing existing debt and supporting the project's lease-up and stabilization. The refinance will save the company millions annually. Aster & Links, a 424-unit luxury multifamily property with over 50,000 sq. ft. of retail, has strong leasing demand and is anchored by Sprouts Farmers Market. Located in downtown Sarasota, it offers hi...
10-09 20:01
JUKI Corporation Transfers JUKI Metal Shares to NOZUK Holdings
Juki Corporation ( ($JP:6440) ) has shared an announcement. JUKI Corporation an...
10-09 14:27
Belpointe OZ Announces that Leasing has Begun at VIV in St. Petersburg, FL
Belpointe OZ’s VIV, a 269-unit mixed-use development in St. Petersburg, FL, has begun leasing with all units receiving Temporary Certificates of Occupancy. Managed by Bozzuto Group, VIV is set to welcome residents starting in November 2025. Located in downtown St. Petersburg, VIV offers modern residences, premium amenities, and ground-floor retail, with convenient access to dining, cultural attractions, and waterfront parks. Belpointe OZ, a publi...
10-06 20:01
Belpointe PREP Secures Major Loans for Sarasota Project
An update from Belpointe PREP ( ($OZ) ) is now available. On September 29, 2025...
10-04 05:51
PowerBank Announces Fiscal Year End Results
1,508% increase in revenues from IPP production supporting the Company's strategy of generating long-term recurring revenues 253% increase in assets fueled by growth of IPP portfolio This ne...
10-02 19:00
Vanda Pharmaceuticals Agrees On A Collaborative Framework With The FDA For The Resolution Of Certain Disputes Regarding Hetlioz And Tradipitant
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that it has agreed on a collaborative framework with the U.S. Food and Drug Administration (FDA) for the resolution of certain disputes regarding
10-02 05:08
Nuvation Bio up after enrollment update, Jefferies’ bullish view
Nuvation Bio (NYSE:NUVB) added ~13% in the morning hours on Tuesday after the cancer drug developer issued an enrollment update related to a Phase 3 program for its lead asset, Ibtrozi (taletrectinib)...
09-30 23:30
United Express Rebrands to OZ VISION INC.
United Express ( ($UNXP) ) just unveiled an update. On September 23, 2025, Unit...
09-30 01:47
Belpointe PREP Subsidiary Sells Land Parcel for $19.3M
Belpointe PREP ( ($OZ) ) has provided an update. On September 15, 2025, Belpoin...
09-20 05:45
Nuvation Bio Says Japan's MHLW Approves IBTROZITM For Treatment Of Adult Patients With ROS1-Positive Unresectable, Advanced And/Or Recurrent NSCLC
IBTROZI will be marketed in Japan by Nippon KayakuApproval is based on the pivotal Phase 2 TRUST studies, demonstrating IBTROZI's high rates and durability of responsesPrimary companion diagnostic approved inIBTROZI will be marketed in Japan by Nippon Kayaku
09-19 19:32
